MET|Analyst Targets
MET|Company Info
MET|Insider Trading
MET|Fundamentals
MET|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $2.64 | - | - |
| Q3'26 | $2.80 | $2.85 | +1.7% |
| Q2'26 | $2.29 | $2.43 | +6.2% |
| Q1'26 | $2.27 | $2.42 | +6.6% |
| Q4'25 | $2.37 | $2.58 | +9.1% |
| Q3'25 | $2.32 | $2.37 | +2.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $20.9B | - | - |
| Q3'26 | $20.2B | $19.9B | -1.3% |
| Q2'26 | $19.9B | $19.1B | -4.2% |
| Q1'26 | $19.4B | $19.7B | +1.3% |
| Q4'25 | $28.0B | $24.2B | -13.6% |
| Q3'25 | - | $17.9B | - |
MET|Monthly Returns
Market Data
MET Stock Snapshot
- Market cap
- 62.89B
- P/E ratio
- 12.3
- Day range
- $97.78 – $102.60
- News sentiment
- 63/100 · Bullish
- Analyst target
- $108.88 (+10.8%)
- Consensus
- Buy · 26 analysts
Price is in the upper part of its 52-week range, and the momentum read backs that positioning up. Earnings and guidance carry more weight than macro data at this capitalisation.
Behaviour On Record
What MET's own history says about today's numbers
- Realized volatility (21d)
- 26.0% 66th pct
- Below its peak
- -4.9%
- vs 200-day average
- +14.1%
- Up days (1y)
- 52%
MetLife, Inc. is currently running 26.0% annualised volatility over the last 21 sessions. Measured against MET's own 13 years of daily returns rather than a market-wide average, that is the 66th percentile — a little above its own norm, against a typical reading of 23.0%.
MET is trading -4.9% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -20.1%, and the deepest was -55.3% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +14.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 88th percentile — a wider gap than this stock usually carries. Over the past year MET closed higher on 52% of sessions, and it is currently 2 sessions into a falling streak.
On November specifically: over 13 years of records, MET finished the month higher 10 of 13 times, with a median return of +3.7% and an average of +4.8%. Its strongest month historically has been November at +4.8% on average, its weakest March at -3.4%.
Overnight risk is measurable too: MET has opened more than 2% away from the prior close in 110 of 3,267 sessions (3.4% of the time), with the largest gaps running +5.9% and -8.3%.
Across the last 4 dated reports on file, MET moved an average of 2.9% in the session after earnings, closing higher 1 of those 4 times, with a median move of -2.3% and a largest of +3.8%.
All figures computed from 3,268 daily closes between 2013-11-08 and 2026-11-06, split-adjusted, recomputed daily. Percentiles are against MET's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of MET's sector?
MetLife, Inc. sits in the Financials sector, currently ranked 6th of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Insurance industry group, MET ranks 4th of 15 tracked industries, leading.
- Sector rank
- #6 of 12
- Sector state
- Leading
- Sector rotation score
- 64
- Industry rank
- #4 of 15
Analyst Consensus Estimates
What do analysts expect MET to earn?
Analysts expect MetLife, Inc. to earn $10.22 per share in the fiscal year ending Dec 2026 and $11.84 in the fiscal year ending Dec 2028, from 5 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.
Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.
Analyst Rating Changes
Are analysts turning bullish or bearish on MET?
TD Cowen most recently reiterated its rating on MetLife, Inc. to Buy on Oct 21, 2026 with a price target of $114 (from $110). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- TD Cowen: Buy
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Earnings Release, Scored
What did MetLife, Inc.'s latest earnings release say?
Most important lines
- 1
increased 12% to $14.1 billion .
New this quarter - 2
$13.5 billion , up 8 percent .
New this quarter - 3
Net income was $2.4 billion , driven by net derivative gains and higher adjusted earnings.
New this quarter
Peers & ETF holders
MET peers & ETF holders
Insurance - LifeMarket cap · today
- METYou're here$62.9B+0.01%
- AFLAflac Incorporated$62.7B-0.95%
- PRUPrudential Financial, Inc.$42.2B-0.02%
- GLGlobe Life Inc.$12.1B-0.48%
News & sentiment
What is the news saying about MET?
MET rose 1.1% over the month to Nov 6. News tone held between 30 and 100 from Oct 6 to Oct 15, then jumped to 94 on Oct 16.
- Oct 8 +2.8%
- Oct 23 -4.4%
- Nov 5 -3.0%same day: MetLife (MET) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Technical analysis
How strong is MET's momentum right now?
On the daily chart MET ranks at the 67th percentile for momentum against 1,060 stocks and ETFs, a bullish reading.
Institutional ownership
Are big funds buying or selling MET?
97 of the 213 tracked managers added to MET in their latest 13F and 113 trimmed. Together they own 64.0% of the company, worth $35.2B. BlackRock and Dodge & Cox alone hold 15.7%.
- 1BlackRock, Inc.8.09%$4.4B positionAdded 0.7% last quarter
- 2Dodge & Cox7.57%$4.1B positionTrimmed 5.3% last quarter
- $3.0B positionTrimmed 1.0% last quarter
- $2.5B positionTrimmed 2.5% last quarter
- 5State Street Corp3.96%$2.1B positionAdded 0.5% last quarter
- 6Morgan Stanley1.96%$1.1B positionAdded 12.7% last quarter
- $1.2B positionTrimmed 7.2% last quarter
- $995.4M positionTrimmed 5.0% last quarter
- $714.5M positionAdded 5.5% last quarter
- 10Invesco Ltd.1.08%$586.3M positionAdded 0.2% last quarter
Congressional trading
Is Congress trading MET?
7 members of Congress disclosed 12 MET trades between Nov 10, 2014 and Mar 27, 2026: 6 buys and 6 sells, about $230.0K in estimated value.
What stands out
Click one to highlight its trades in the chartDiscover more
How has MET done against its peers?
Over the six months to Nov 6, MET returned +22.7%. Of the 15 related stocks and ETFs, 3 did better, led by AJG at +41.0%.
- 1AJGArthur J. Gallagher & Co.up 41.0%+18.3 pts
- 2TRVThe Travelers Companies, Inc.up 31.0%+8.4 pts
- 3WTWWillis Towers Watson Public Limited Companyup 30.8%+8.1 pts
- 4METThis stockup 22.7%
- 5PRUPrudential Financial, Inc.up 19.7%−3.0 pts
- 6ALLThe Allstate Corporationup 18.7%−4.0 pts
- 7PGRThe Progressive Corporationup 15.7%−6.9 pts
- 8KIESPDR S&P Insurance ETFup 14.1%−8.6 pts
- 16SLFSun Life Financial Inc.down 2.1%−24.8 pts